Food Saf (Tokyo). 2023 Jun 23;11(2):36-39. doi: 10.14252/foodsafetyfscj.D-23-00007. eCollection 2023 Jun.
Food Safety Commission of Japan (FSCJ) conducted a risk assessment of a sulfonanilide herbicide, dimesulfazet (CAS No. 1215111-77-5), based on results from various studies. The data used in the assessment include the fate in plants (paddy rice), residues in crops, fate in animals (rats), subacute toxicity (rats, mice and dogs), chronic toxicity (dogs), combined chronic toxicity/carcinogenicity (rats), carcinogenicity (mice), acute neurotoxicity (rats), subacute neurotoxicity (rats), two-generation reproductive toxicity (rats), developmental toxicity (rats and rabbits), and genotoxicity. The major adverse effects of dimesulfazet from those test results were observed in body weight (suppressed body weight gain in all test results), kidneys (increased weight in rats) and urinary bladder (urothelial hyperplasia in mice and dogs). None of carcinogenicity, neurotoxicity and genotoxicity were observed. No obvious effects on fertility were detected. The lowest no-observed-adverse-effect level (NOAEL) obtained from all the studies was 0.39 mg/kg bw per day in two-year combined chronic toxicity/carcinogenicity study in rats. On the basis of this value, FSCJ specified an acceptable daily intake (ADI) of 0.0039 mg/kg bw per day after applying a safety factor of 100 to the NOAEL. The lowest NOAEL for potential adverse effects after a single oral administration of dimesulfazet was 15 mg/kg bw per day in the developmental toxicity study in rabbits. FSCJ thus specified an acute reference dose (ARfD) of 0.15 mg/kg bw after applying a safety factor of 100 for women who are pregnant or might be pregnant. For the general population, an ARfD of 0.41 mg/kg bw after applying a safety factor of 300 (additional factor 3 by applying LOAEL of 125 mg/kg bw resulted from acute neurotoxicity study in rats).
日本食品安全委员会(FSCJ)基于各项研究结果,对磺酰苯胺类除草剂双甲磺草胺(化学物质登记号:1215111-77-5)进行了风险评估。评估中使用的数据包括在植物(水稻)中的代谢情况、作物中的残留量、在动物(大鼠)体内的代谢情况、亚急性毒性(大鼠、小鼠和狗)、慢性毒性(狗)、慢性毒性/致癌性联合研究(大鼠)、致癌性(小鼠)、急性神经毒性(大鼠)、亚急性神经毒性(大鼠)、两代生殖毒性(大鼠)、发育毒性(大鼠和兔子)以及遗传毒性。从这些测试结果来看,双甲磺草胺的主要不良反应体现在体重(所有测试结果中体重增加均受抑制)、肾脏(大鼠肾脏重量增加)和膀胱(小鼠和狗的膀胱上皮增生)。未观察到致癌性、神经毒性和遗传毒性。未检测到对生育能力有明显影响。在大鼠的两年慢性毒性/致癌性联合研究中,所有研究得出的最低未观察到有害作用水平(NOAEL)为每天0.39毫克/千克体重。基于该值,日本食品安全委员会在对NOAEL应用100的安全系数后,确定每日允许摄入量(ADI)为每天0.0039毫克/千克体重。在兔子的发育毒性研究中,单次口服双甲磺草胺后潜在不良反应的最低NOAEL为每天15毫克/千克体重。因此,日本食品安全委员会在对怀孕或可能怀孕的女性应用100的安全系数后,确定急性参考剂量(ARfD)为0.15毫克/千克体重。对于一般人群,在应用300的安全系数后(因大鼠急性神经毒性研究得出的最低观察到有害作用水平为125毫克/千克体重而增加3倍系数),急性参考剂量为0.41毫克/千克体重。